MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma

Carcinogenesis

Volumn 33, Issue 6, 2012, Pages 1134-1141

  Law, Priscilla T Y ^a   Ching, Arthur K K ^a   Chan, Anthony W H ^a   Wong, Queenie W L ^a   Wong, Chun Kwok ^a   To, Ka Fai ^a   Wong, Nathalie ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LUCIFERASE; MICRORNA 145; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR;

3' UNTRANSLATED REGION; ALGORITHM; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; CELL VIABILITY; COHORT ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; M PHASE CELL CYCLE CHECKPOINT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DISEASE-FREE SURVIVAL; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIVER; LIVER NEOPLASMS; MICRORNAS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 84864183740     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs130     Document Type: Article

References (40)

1. Lee,R.C. et al. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854.
2. Meng,F. et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
3. Wong,Q.W. et al. (2010) MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin. Cancer Res., 16, 867-875.
4. Varnholt,H. et al. (2008) MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology, 47, 1223-1232.
5. Lan,F.F. et al. (2011) Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int. J. Cancer, 128, 319-331.
6. Johnson,S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
7. Schepeler,T. et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res., 68, 6416-6424.
8. Iorio,M.V. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070.
9. Jemal,A. et al. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
10. Wong,Q.W. et al. (2008) MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology, 135, 257-269.
11. Liu,W.H. et al. (2009) MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology, 136, 683-693.
12. Breuhahn,K. et al. (2008) Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J. Gastroenterol., 14, 1690-1698.
13. Cantarini,M.C. et al. (2006) Aspartyl-asparagyl beta hydroxylase overexpression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology, 44, 446-457.
14. Tanaka,S. et al. (1997) Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes. Hepatology, 26, 598-604.
15. Boissan,M. et al. (2005) Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Am. J. Pathol., 167, 869-877.
16. Sedlaczek,N. et al. (2003) Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis. Br. J. Cancer, 88, 733-739.
17. Breuhahn,K. et al. (2004) Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Cancer Res., 64, 6058-6064
18. Jiang,J. et al. (2008) Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res., 14, 419-427.
19. Iorio,M.V. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707.
20. Wong,N. et al. (2005) Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells. Clin. Cancer Res., 11, 1319-1326.
21. Dearth,R.K. et al. (2006) Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol. Cell Biol., 26, 9302-9314.
22. Longato,L. et al. (2009) Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology, 49, 1935-1943.
23. Michael,M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
24. Yanaihara,N. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
25. Cummins,J.M. et al. (2006) The colorectal microRNAome. Proc. Natl Acad. Sci. USA, 103, 3687-3692.
26. Li,J. et al. (2011) Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. Biochem. Biophys. Res. Commun., 406, 70-73.
27. Wong,C.C. et al. (2011) The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rhokinase Gastroenterology, 140, 322-331.
28. Zhang,J. et al. (2010) microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer, 103, 1215-1220.
29. Law,P.T. et al. (2011) Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J. Gastroenterol. Hepatol., 26, 437-449.
30. Inui,M. et al. (2010) MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol., 11, 252-263.
31. Shi,B. et al. (2007) Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J. Biol. Chem., 282, 32582-32590.
32. Mardilovich,K. et al. (2009) Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun. Signal., 7, 14.
33. Peruzzi,F. et al. (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell Biol., 19, 7203-7215.
34. Taouis,M. et al. (1998) Insulin receptor substrate 1 antisense expression in an hepatoma cell line reduces cell proliferation and induces overexpression of the Src homology 2 domain and collagen protein (SHC). Mol. Cell Endocrinol., 137, 177-186.
35. Cesarone,G. et al. (2006) RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J. Cell. Biochem., 98, 440-450.
36. Tanaka,S. et al. (1996) Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis. Cancer Res., 56, 3391-3394.
37. Stromberg,T. et al. (2006) IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. Blood, 107, 669-678.
38. Kalebic,T. et al. (1994) In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and downregulates p34cdc2. Cancer Res., 54, 5531-5534.
39. Nusse,R. (2005) Wnt signaling in disease and in development. Cell Res., 15, 28-32.
40. Kota,J. et al. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 137, 1005-1017